Defence Therapeutics Inc. (CSE:DTC)
Canada · Delayed Price · Currency is CAD 0.7700
0.00 (0.00%)
Oct 31, 2025, 1:02 PM EDT
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 42.14 million as of October 31, 2025. Its market cap has increased by 56.84% in one year.
Market Cap
42.14M
Enterprise Value
42.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.77
Market Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 42.14M, a decrease of -52.70%. That is a compound annual growth rate of -15.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 42.14M | 33.85% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
| May 7, 2021 | 89.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.09B |
| Green Thumb Industries | 2.30B |
| dentalcorp Holdings | 2.18B |
| Trulieve Cannabis | 1.89B |
| Sienna Senior Living | 1.81B |
| Extendicare | 1.34B |
| Cronos Group | 1.33B |
| WELL Health Technologies | 1.32B |